Clinical Trial

A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the clinical efficacy of a traditional Chinese medicine formula granule (Feireqing Granules) in the treatment of severe pneumonia caused by multidrug-resistant Gram-negative bacterial infections (MDR-GNB severe pneumonia), to establish a therapeutic regimen, and to generate high-quality clinical evidence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-26.
Status change: Not Yet Recruiting → Recruiting 2026-07-07
Trial Details
NCT Number NCT07206745
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: Henan Provincial Hospital of TCM, Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Conditions Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
Enrollment 152 participants
Start Date 2025-12-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09